Safety of octreotide in hospitalized infants
Octreotide is used off-label in infants for treatment of chylothorax, congenital hyperinsulinism, and gastrointestinal bleeding. The safety profile of octreotide in hospitalized infants has not been described; we sought to fill this information gap.
| Veröffentlicht in: | Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics. - 2014. - Amsterdam [u.a.] |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2015
|
| Zugriff auf das übergeordnete Werk: | Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| Umfang: | 6 |
| Zusammenfassung: | Octreotide is used off-label in infants for treatment of chylothorax, congenital hyperinsulinism, and gastrointestinal bleeding. The safety profile of octreotide in hospitalized infants has not been described; we sought to fill this information gap. |
|---|---|
| Beschreibung: | 6 |
| DOI: | 10.1016/j.earlhumdev.2015.04.008 |